Healthcare · Drug Manufacturers General · NYSE
| Market cap | $468.66B |
|---|---|
| Trailing P/E | 24.4 |
| FCF yield | 3.8% |
| Revenue growth (YoY) | +8.6% |
| EPS growth (YoY) | -1.2% |
| FCF/share growth (YoY) | -0.1% |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
AbbVie Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Pete Sessions | House | Sell | $15,001 - $50,000 | Sep 18, 2026 |
| Alan Armstrong | Senate | Buy | $15,001 - $50,000 | Jul 21, 2026 |
| Alan Armstrong | Senate | Buy | $15,001 - $50,000 | Jul 21, 2026 |
| Josh Gottheimer | House | Sell | $1,001 - $15,000 | Jun 3, 2026 |
| Julie Johnson | House | Sell | $1,001 - $15,000 | Jan 15, 2026 |
| Julia Letlow | House | Buy | $1,001 - $15,000 | Jan 13, 2026 |
| Julia Letlow | House | Buy | $1,001 - $15,000 | Jan 13, 2026 |
| Julie Johnson | House | Sell | $1,001 - $15,000 | Dec 11, 2025 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Nov 21, 2025 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Nov 21, 2025 |
| Julie Johnson | House | Sell | $1,001 - $15,000 | Sep 11, 2025 |
| Ritchie John Torres | House | Buy | $1,001 - $15,000 | Aug 20, 2025 |